Type / Class
Equity / Class A Common Stock, par value $0.0001 per share
Shares outstanding
126M
Number of holders
118
Total 13F shares, excl. options
68.4M
Shares change
-998K
Total reported value, excl. options
$289M
Value change
-$3.81M
Number of buys
49
Number of sells
-61
Price
$4.22

Significant Holders of Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) as of Q3 2025

136 filings reported holding ORGO - Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share as of Q3 2025.
Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) has 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 68.4M shares of 126M outstanding shares and own 54.17% of the company stock.
Largest 10 shareholders include Soleus Capital Management, L.P. (12.1M shares), MORGAN STANLEY (11.8M shares), First Light Asset Management, LLC (7.5M shares), VANGUARD GROUP INC (5.04M shares), Assenagon Asset Management S.A. (4.85M shares), BlackRock, Inc. (4.58M shares), DEUTSCHE BANK AG\ (3.28M shares), DIMENSIONAL FUND ADVISORS LP (2.91M shares), ACADIAN ASSET MANAGEMENT LLC (1.75M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.72M shares).
This table shows the top 118 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.